O'Shaughnessy Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-578	Closed	-$76K	–	2528
2020 Q4	$76K	Buy	+578	New	+$51.1K	﹤0.01%	1150

O'Shaughnessy Asset Management's EIDX Position: Q1 2021 in Review

O'Shaughnessy Asset Management sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 578 shares — an estimated $76K sold.

O'Shaughnessy Asset Management first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $76K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

O'Shaughnessy Asset Management reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 578 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $76K.
O'Shaughnessy Asset Management first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
O'Shaughnessy Asset Management's Eidos Therapeutics, Inc. Common Stock position peaked at $76K in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2021, filed 14 May 2021.